IRF5 and neoplasm: The co-delivery of IRF5 mRNA and CCL5 siRNA allows for the upregulation of IRF5 and downregulation of CCL5, which can help contribute to a significant increase in M1 phenotype macrophages, which can help reduce tumor growth as M1 macrophages can initiate T cell-mediated immune responses.